Endoscopy, Papillary Thyroid Carcinoma, Thyroid Cancer, Thyroidectomy
Conditions
Keywords
Endoscopy, Thyroidectomy, Thyroid Cancer
Brief summary
Endoscopic thyroidectomy developed rapidly in recent years, and the most popular surgical approach was endoscopic thyroidectomy by bilateral areola approach, but some operative steps was required optimization. One of the most annoying problem was the smog blurring endoscopic lens during surgery. The researcher summarized a set of convenient foot-control exhaust method and carried out this prospective study.
Detailed description
The patients with papillary thyroid microcarcinoma were included according to the inclusive criteria and randomly divided them into two groups (foot-control exhaust group and direct exhaust group). The foot-control exhaust group used the foot-control exhaust method by the way of adjustable Pressure to intermittent exhaust, while direct exhaust group exhaust through the Trocar hole. Comparison of operation time, times of wiping the endoscopic lens, volume of postoperative drainage, and number of identified parathyroid gland between two groups.
Interventions
DEVICEused of the Pressure adjustable foot-control method
Whether The Pressure adjustable foot-control method is used.
DEVICEdirect exhaust
direct exhaust through the trocar.
Sponsors
Bo Wang,MD
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Intervention model description
This study is a prospective randomized controlled study to select a continuous case of thyroid surgery in the fujian medical university union hospital from January 2017 to June 2017.
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
1. Patients with maximum tumor diameter ≤1 cm; 2. patients without lateral neck lymph node metastases; 3. patients without distant metastases; 4. patients who only needed unilateral surgery following the guidelines; 5. patients with strong cosmetic requirement.
Exclusion criteria
1. Patients with maximum tumor diameter \>1 cm; 2. patients who needed complement total thyroidectomy according to the guidelines, including tumor extrathyroidal extension as well as large amount of neck lymph node metastases and distant metastases; 3. patients without cosmetic requirements.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Central lymph node dissection time | 1 day after surgery | Central lymph node dissection time: was from separating central lymph node to the specimen removed. |
| Flap separation time | 1 day after surgery | Flap separation time was acquired from endoscopic video was the period from endoscopy into the body to building up operation space. |
| Glandular excision time | 1 day after surgery | Glandular excision time was defined from incising cervical white line to removing Berry ligament. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The number of identifying parathyroid glands | 1 day after surgery | The number of identifying parathyroid glands was evaluated at postoperation while parathyroid glands was identified during surgery. |
| Times of wiping lens | 1 day after surgery | Times of wiping lens calculated from endoscopic video after operation was defined the times of wiping lens from endoscopy into the body to central lymph node removed. |
| Blood calcium level | before surgery, the first day after surgery, one week after surgery, two months after surgery. | to measure the blood calcium level in the blood |
| Blood PTH level | preoperative, first day after operation, one week after surgery, two months after surgery. | measurement of PTH level in blood |
| Volume of intraoperative blood loss | 1 day after surgery | Volume of intraoperative blood loss was estimated the volume of intraoperative blood loss. |
| Volume of Postoperative drainage | 1 day，2 day，3 day after surgery | Volume of Postoperative drainage was accurately calculated the total volume while the drainage tube removed after operation. |
Countries
China
Contacts
Primary ContactWen-xin ZHAO, MD
Outcome results
None listed